Is $CRVS pump-proof?

Corvus Pharmaceuticals, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-10-31.

$CRVS
Corvus Pharmaceuticals, Inc.
CLEAR RISK
27
/ 100 trap score
Price and crowd are quiet right now, but there's dilution machinery on file. Quiet isn't the same as clean; a rally here feeds the share printer.
Hype / crowding
13
Run-up / extension
5
Structural risk
73
$Live ATM program (424B5, 8 months ago): an at-the-market agreement lets the company sell new shares into the market continuously, including right now [424B5 (ATM) 2026-03-13]↗
🔒 3 more filings flagged on $CRVS: see all of them free.
All 4 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-10-31 · not financial advice

The record on $CRVS

first scored Aug 1: -24% since
25Aug 1
27Oct 15
27Oct 16
26Oct 17
31Oct 21
27Oct 29
26Oct 30
27Oct 31
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What an ATM offering is →What a shelf registration is →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.